Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?

Olmez, O. F.Bilici, A.Gursoy, P.Cubukcu, E.Yildiz, O.Sakin, A.Hamdard, J.2020-12-012020-12-0120191556-08641556-1380https://doi.org/10.1016/j.jtho.2019.08.1152https://hdl.handle.net/11454/63352DEMIR, TARIK/0000-0001-6334-4079[No abstract available]en10.1016/j.jtho.2019.08.1152info:eu-repo/semantics/openAccessInflammation-based prognostic scoresNon small cell lung cancerAnaplastic lymphoma kinaseAre Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?Conference Object1410S551S552WOS:000492162203068Q1